Shares of Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) were up 21.2% during trading on Thursday . The stock traded as high as C$0.21 and last traded at C$0.20. Approximately 283,894 shares were traded during mid-day trading, a decline of 47% from the average daily volume of 537,850 shares. The stock had previously closed at C$0.17.
Voyageur Pharmaceuticals Stock Down 10.0 %
The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21. The business has a 50-day moving average price of C$0.11 and a 200 day moving average price of C$0.08. The stock has a market capitalization of C$25.10 million, a P/E ratio of -18.00 and a beta of 0.32.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Featured Articles
- Five stocks we like better than Voyageur Pharmaceuticals
- What is the Shanghai Stock Exchange Composite Index?
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
- 3 Healthcare Dividend Stocks to Buy
- Microsoft and Meta’s AI Investment Plans Are Full Steam Ahead
- How Technical Indicators Can Help You Find Oversold Stocks
- Beyond Self-Driving Cars: Factory Automation Takes Center Stage
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
